Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
34 participants
OBSERVATIONAL
2011-11-30
2012-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Correlation Between Release of Cytokines From Liver Graft and Hemodynamic Instability
NCT01120743
Study of Heart Transplant Rejection
NCT00042614
The Role of Connective Tissue Growth Factor in the Development of Kidney Disease After Organ Transplantation
NCT00056784
Noninvasive Evaluation of Cardiac Allograft Vasculopathy
NCT01305382
Exploration of Fatigue, Uncertainty, Depression and Quality of Life in Heart Transplantation Recipients
NCT01182571
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
Heart Transplant Recipients with Unexplained Graft Dysfunction
No interventions assigned to this group
Group 2
Normal Control
No interventions assigned to this group
Group 3
Class III-IV Heart Failure
No interventions assigned to this group
Group 4
Heart Transplant Recipients with Normal Graft Function
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years and older
* Cardiac Transplant recipient with graft dysfunction of unknown etiology
Group 2
* 18 years or older
* No history of heart failure or cardiac transplantation Group 3
* 18 years or older
* Class II-IV heart failure Group 4
* 18 years or older
* Heart Transplant 6 months or greater prior to blood draw
* No graft dysfunction
Exclusion Criteria
* Cellular or antibody-mediated cardiac allograft dysfunction
Group 2 Normal Control group
* Active infection within 1 month of blood draw
* Known Inflammatory Disease
Group 3 Heart Failure Group
* Active infection within 1 month of blood draw
* Known Inflammatory Disease
Group 4 Heart Transplant with Normal Graft Function Group
* Active infection within 1 month of blood draw
* Known graft dysfunction
* Known Inflammatory Disease
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter M Eckman, MD
Role: PRINCIPAL_INVESTIGATOR
University of Minnesota
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1111M06547
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.